Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis
Recruiting
Phase 4
Interventional Study
Multiple Sclerosis
Lower Urinary Track Symptoms
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Atlantic Health System · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if silodosin works to treat lower urinary tract symptoms (LUTS) in female patients with multiple sclerosis (MS). It will also learn about the effect of the drug on voiding parameters. The main questions it aims to answer are:
Does silodosin improve lower urinary tract symptoms based on questionnaires? Does silodosin change Uroflowmetry parameters in fem…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Female patients with a diagnosis of multiple sclerosis
2. Age \> 18
3. Moderate to severe lower urinary tract symptoms as defined by an AUASS score \> 8
4. No UTI
Exclusion Criteria:
1. Treatment with alpha-blocker, B3 agonist, or anticholinergic medication within the last …
Contacts